Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Company News

As of June 10, 2025 • 9:31 AM ET

Date/Time Source News Release
05/14/2025 06:50 AM EDT PR Newswire Protalix BioTherapeutics to Present at the 3rd Annual H.C. Wainwright BioConnect Investor Conference at Nasdaq NYC
05/09/2025 06:50 AM EDT PR Newswire Protalix BioTherapeutics Reports First Quarter 2025 Financial and Business Results
05/05/2025 06:50 AM EDT PR Newswire Protalix BioTherapeutics to Announce First Quarter 2025 Financial and Business Results on May 9, 2025
03/24/2025 06:50 AM EDT PR Newswire Protalix BioTherapeutics to Present at the iAccess Alpha Virtual Best Ideas Spring Conference 2025
03/21/2025 09:00 AM EDT ACCESS Newswire iAccess Alpha's Virtual Best Ideas Spring Investment Conference March 25-26, 2025
03/17/2025 06:50 AM EDT PR Newswire Protalix BioTherapeutics Reports Fiscal Year 2024 Financial and Business Results
03/10/2025 06:50 AM EDT PR Newswire Protalix BioTherapeutics to Announce Fiscal Year 2024 Financial and Business Results on March 17, 2025
02/04/2025 06:50 AM EST PR Newswire Protalix BioTherapeutics to Participate in the 2025 BIO CEO & Investor Conference
12/23/2024 06:50 AM EST PR Newswire Protalix BioTherapeutics Issues 2025 Letter to Stockholders
12/09/2024 06:30 AM EST PR Newswire Chiesi Global Rare Diseases and Protalix BioTherapeutics Announce Validation of Variation Submission by European Medicines Agency for pegunigalsidase alfa
Page

Additional News

As of June 10, 2025 • 9:31 AM ET

Date/Time Source News Release
05/09/2025 04:13 PM EDT SeekingAlpha Protalix BioTherapeutics targets phase 2 launch for PRX-115 in H2 2025
05/09/2025 04:12 PM EDT SeekingAlpha Protalix BioTherapeutics, Inc. (PLX) Q1 2025 Earnings Call Transcript
05/09/2025 06:56 AM EDT SeekingAlpha Protalix BioTherapeutics GAAP EPS of -$0.05 misses by $0.13, revenue of $10.11M misses by $11.49M
05/08/2025 12:54 PM EDT SeekingAlpha Protalix BioTherapeutics Q1 Earnings Preview
04/10/2025 09:54 AM EDT SeekingAlpha Protalix BioTherapeutics Is A Strong Buy With Increasing Revenues And A Promising Pipeline
03/17/2025 10:23 AM EDT SeekingAlpha Protalix plans Phase 2 for PRX-115 in H2 2025, projects higher royalty revenues by 2030
03/17/2025 10:22 AM EDT SeekingAlpha Protalix BioTherapeutics, Inc. (PLX) Q4 2024 Earnings Call Transcript
03/17/2025 07:02 AM EDT SeekingAlpha Protalix BioTherapeutics GAAP EPS of $0.04, revenue of $53.4M
03/16/2025 08:00 AM EDT SeekingAlpha Earnings week ahead: FDX, GIS, NIO, XPEV, MU, NKE, CCL, ACN and more
03/14/2025 02:49 PM EDT SeekingAlpha Protalix BioTherapeutics Q4 Earnings Preview
Page

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.